Atlantic Biologicals Corporation Enters into Deferred Prosecution Agreement in Opioid Distribution Scheme

Atlantic Biologicals Corporation Enters into Deferred Prosecution Agreement in Opioid Distribution Scheme

Company Admits to Receiving More than $2.5 Million from Sales of Opioids and Other Commony Abused Prescription Drugs to Houston-Area Pill Mill Pharmacies

Atlantic Biologicals Corporation, a pharmaceutical wholesaler based in Miami, has entered into a two-year deferred prosecution agreement with the Justice Department in connection with a criminal information filed in the Southern District of Florida charging it with one count of conspiracy to unlawfully distribute and dispense, and possess with intent to distribute, controlled substances. As part of the deferred prosecution agreement, Atlantic Biologicals admitted that its business unit National Apothecary Solutions (NAS), through its employees and agents, sold opioid pills to certain Houston area pill mill pharmacies, knowing and intending that the pharmacies would dispense the pills outside the usual course of professional practice and without a legitimate medical purpose. NAS commenced cessation of operations in or about November 2025, after selling over 14 million doses of opioids and opioid potentiators to pill mill pharmacies in the diversion "hot zone" of Houston, Texas.

Read more on https://www.justice.gov